1-((2S,5R)-2-methyl-5-((5-(2-(prop-2-yn-1-yloxy)ethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)prop-2-en-1-one

Catalog No. :
ACKZRL599
CAS No. :
2042629-43-4
Molecular Formula :
C20H25N5O2
Molecular Weight :
367.45

IUPAC Name:1-((2S,5R)-2-methyl-5-((5-(2-(prop-2-yn-1-yloxy)ethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)prop-2-en-1-one

1-((2S,5R)-2-methyl-5-((5-(2-(prop-2-yn-1-yloxy)ethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)prop-2-en-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg95%$566.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-((2S,5R)-2-methyl-5-((5-(2-(prop-2-yn-1-yloxy)ethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)prop-2-en-1-one
IUPAC Name1-((2S,5R)-2-methyl-5-((5-(2-(prop-2-yn-1-yloxy)ethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)prop-2-en-1-one
Molecular FormulaC20H25N5O2
Molecular Weight367.45
SMILESN(C1=C2C(NC=C2CCOCC#C)=NC=N1)[C@H]3CN(C(C=C)=O)[C@@H](C)CC3
InChI KeyOQQBLYFXQMNSIZ-GOEBONIOSA-N
Synonym2-Propen-1-one, 1-[(2S,5R)-2-methyl-5-[[5-[2-(2-propyn-1-yloxy)ethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]-;Ritlecitinib Impurity 39
CAS No.2042629-43-4

Synthetic Route by SureRoute

1. ACKZRL599 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKZRL599 route product structure diagram
    ACKZRL5992042629-43-4
Inquiry

2. ACKZRL599 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQRUC102 route compound structure diagram
    ACQRUC10213270-28-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKZRL599 route product structure diagram
    ACKZRL5992042629-43-4
Inquiry

Comments (0)